Tagged Articles

Risperdal side effects 110 articles

Former FDA chief to testify on Xarelto makers’ conduct

In January 2015, former Food and Drug Administration (FDA) Commissioner David Kessler testified in a Philadelphia court that five years before Johnson & Johnson subsidiary Janssen Pharmaceuticals added warnings to its antipsychotic Risperdal regarding a side effect involving disfiguring breast growth in adolescent boys, the company was aware of its danger to minors. It was the first bellwether trial among thousands involving claims that Janssen tried to cover up Risperdal side effects. Kessler testified that Risperdal “probably or very likely” triggered breast growth in boys – a condition called gynecomastia. He backed up that claim by referencing a 2001 study ... Read More

Family vows to appeal judge’s decision to ax Risperdal side effects case

The latest lawsuit to go to trial in the Philadelphia Country Court of Common Pleas involving claims that the antipsychotic drug Risperdal caused an adolescent boy to grow disfiguring female breasts was axed mid-trial by the judge overseeing the case because the judge did not support the expert witness’ diagnosis of gynecomastia based solely on photographs. The family of the boy vowed to appeal. The lawsuit is one of more than 5,700 claims in a mass tort program in Philadelphia County alleging Risperdal makers Johnson & Johnson and its subsidiary Janssen Pharmaceuticals withheld data showing that Risperdal use in adolescent boys ... Read More

Risperdal lawsuits increasing in PA mass tort program

More than 3,000 new Risperdal lawsuits were filed in the first quarter of 2017, increasing the number of filings in the mass tort program to more than 5,500, according to the Philadelphia County Court of Common Pleas. Attorneys for plaintiffs suing the makers of Risperdal over claims that the antipsychotic drug could cause disfiguring side effects are cautioning consumers that the clock is now clicking on similar claims with the possibility of a statue of limitations now looming. Risperdal, known chemically as risperidone, is used to treat adults and children with schizophrenia, bipolar disorder, and irritability with autism. The drug ... Read More

Many children with autism given antipsychotics without prior behavioral therapy

Many children with autism are started on antipsychotic medications, many of which have harsh side effects, without trying safer options such as behavioral therapy, according to a study conducted by researchers at Bloorview Research Institute in Toronto, Canada. “The most important thing is to teach our kids skills that will allow them to learn how to regulate their own arousal level, emotions and behaviors before we give medication,” says lead investigator Evdokia Anagnostou. “Medications do not teach skills; they’re Band-Aids.” Antipsychotic medication, like Risperdal, is used to treat irritability in adults and children with autism. But these medications carry side ... Read More

Risperdal was ‘worst mistake’ for one adolescent boy

Eddie Bible says taking the antipsychotic Risperdal was the worst mistake of his life. “If I knew what the side effects would be …I would have never taken it,” he told the Deccon Chronicle. Bible was prescribed Risperdal as a child to treat anxiety and bipolar disorder. The drug is also used to treat schizophrenia and irritability with autism. By the time Bible reached high school, he had developed large, female-like breasts, a condition clinically referred to as gynecomastia but one Bible called embarrassing. “I had larger boobs than the girls in school,” he said. “I thought, ‘Am I going to ... Read More

Psychologist: ADHD is a farce and treating it exposes kids to side effects

The pharmaceutical industry is no fan of Jerome Kagan, noted psychologist and professor at Harvard University. He says attention-deficit hyperactivity disorder (ADHD) is a farce and that parents are needlessly doping their kids so they won’t be so unruly. “(ADHD) is an invention. Every child who’s not doing well in school is sent to see a pediatrician, and the pediatrician says: ‘It’s ADHD; here’s Ritalin.’ In fact, 90 percent of these 5.4 million (ADHD-diagnosed) kids don’t have an abnormal dopamine metabolism. The problem is, if a drug is available to doctors, they’ll make the corresponding diagnosis,” Dr. Kagan said. He doesn’t ... Read More

New study pits Risperdal against newer antipsychotic Vraylar

A study pitting the popular antipsychotic Risperdal against the new treatment Vraylar in a pool of patients with schizophrenia found that the newer drug did a better job of improving negative symptoms of the disease than its decades-old counterpart. Risperdal, first approved by the Food and Drug Administration (FDA) in 1993, contains the active ingredient risperidone. It is now indicated for adults and children with schizophrenia, bipolar disorder, and irritability with autism. It is sometimes prescribed off-label to treat behavioral conditions including ADHD. Vraylar, known chemically as cariprazine, was FDA approved in 2015 to treat schizophrenia and acute manic or ... Read More

FDA seeks public input regarding treatment options for autism

The Food and Drug Administration (FDA) is holding a public meeting this spring to gain insight from people with autism and their families regarding new pharmaceutical treatments for the developmental condition. “The public meeting is intended to allow FDA to obtain patient perspectives on the impact of autism on daily life as well as patient views on treatment approaches for autism,” the FDA said in a public notice. Autism is one of 20 conditions the FDA aims to seek input on to better understand the impact diagnoses have on patients’ daily lives, the types of treatments that benefit patients most, ... Read More

J&J faces wave of lawsuits over pharmaceuticals, medical devices, health care products

Johnson & Johnson and its subsidiaries are being hit by a growing wave of lawsuits alleging the world’s largest health care company’s pharmaceuticals, medical devices and health care products cause serious injuries and deaths. More than 100,000 people, including 18,500 men who claim they grew disfiguring female-like breasts after taking the antipsychotic Risperdal as adolescents, sued J&J in 2016 – an increase of about 28,3000 over the previous year. J&J disclosed that its litigation expenses to fight these claims jumped 480 percent in 2016 to a whopping $817 million. Plaintiffs suing J&J and its subsidiary Janssen Pharmaceuticals over Risperdal side ... Read More

Antipsychotics market expected to grow through 2021

A growing aging population and increased prevalence of neurological disorders in the region contributes to North America’s dominance in antipsychotic sales in the global market, and sales of these drugs is expected to grow at a significant rate through 2021, according to market research company Persistence Market Research Antipsychotics are a group of medicines that are used to treat mental illnesses such as schizophrenia, schizoaffective disorder, bipolar disorder, and psychotic depression. They are also used to treat severe depression, anxiety, autism, and other behavioral conditions including ADHD. A growing awareness regarding different neurological disorders and their available treatment are expected to help ... Read More